@article{JTD23871,
author = {Alain Fraisse and Monica Latchman and Shiv-Raj Sharma and Selin Bayburt and Pascal Amedro and Giovanni di Salvo and Alban Elouen Baruteau},
title = {Atrial septal defect closure: indications and contra-indications},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 24},
year = {2018},
keywords = {},
abstract = {Transcatheter closure has become an accepted alternative to surgical repair for ostium secundum atrial septal defects (ASD). However, large ASDs (>38 mm) and defects with deficient rims are usually not offered transcatheter closure but are referred for surgical closure. Transcatheter closure also remains controversial for other complicated ASDs with comorbidities, additional cardiac features and in small children. This article not only provides a comprehensive, up-to-date description of the current indications and contra-indications for ASD device closure, but also further explores the current limits for transcatheter closure in controversial cases. With the devices and technology currently available, several cohort studies have reported successful percutaneous closure in the above-mentioned complex cases. However the feasibility and safety of transcatheter technique needs to be confirmed through larger studies and longer follow-up.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23871}
}